On the public citation graph
Long‐Term Outcomes in Juvenile Idiopathic Arthritis: Eighteen Years of Follow‐Up in the Population‐Based Nordic Juvenile Idiopathic Arthritis Cohort
0 signed · 225 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/acr.20460openalex-snapshot
2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: Initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features
inferredcites →https://doi.org/10.1002/acr.20497openalex-snapshot
American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis
inferredcites →https://doi.org/10.1002/acr.22087openalex-snapshot
2013 Update of the 2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for the Medical Therapy of Children With Systemic Juvenile Idiopathic Arthritis and Tuberculosis Screening Among Children Receiving Biologic Medications
inferredcites →https://doi.org/10.1002/art.1780230202openalex-snapshot
Measurement of patient outcome in arthritis
inferredcites →https://doi.org/10.1002/art.21119openalex-snapshot
Development and validation of a clinical index for assessment of long‐term damage in juvenile idiopathic arthritis
inferredcites →https://doi.org/10.1002/art.24516openalex-snapshot
Development and validation of a composite disease activity score for juvenile idiopathic arthritis
inferredcites →https://doi.org/10.1002/art.27431openalex-snapshot
Long‐term safety and efficacy of abatacept in children with juvenile idiopathic arthritis
inferredcites →https://doi.org/10.1002/art.30426openalex-snapshot
Ongoing disease activity and changing categories in a long‐term nordic cohort study of juvenile idiopathic arthritis
inferredcites →https://doi.org/10.1002/art.34343openalex-snapshot
Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis
inferredcites →https://doi.org/10.1002/art.34373openalex-snapshot
Remission, minimal disease activity, and acceptable symptom state in juvenile idiopathic arthritis: Defining criteria based on the juvenile arthritis disease activity score
inferredcites →https://doi.org/10.1007/s10067-017-3540-xopenalex-snapshot
Remission rate is not dependent on the presence of antinuclear antibodies in juvenile idiopathic arthritis
inferredcites →https://doi.org/10.1007/s11926-017-0702-4openalex-snapshot
Clinical Outcome and Long-term Remission in JIA
inferredcites →https://doi.org/10.1016/j.semarthrit.2017.05.007openalex-snapshot
How common is remission in juvenile idiopathic arthritis: A systematic review
inferredcites →https://doi.org/10.1056/nejm200003163421103openalex-snapshot
Etanercept in Children with Polyarticular Juvenile Rheumatoid Arthritis
inferredcites →https://doi.org/10.1093/rap/rkz031openalex-snapshot
Short-term outcome of surgical arthrodiastasis of the ankle with Ilizarov frame in a cohort of children and young people with juvenile idiopathic arthritis
inferredcites →https://doi.org/10.1136/annrheumdis-2011-200237openalex-snapshot
Validity and predictive ability of the juvenile arthritis disease activity score based on CRP versus ESR in a Nordic population-based setting
inferredcites →https://doi.org/10.1136/annrheumdis-2013-204573openalex-snapshot
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
inferredcites →https://doi.org/10.1136/annrheumdis-2014-205372openalex-snapshot
The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort
inferredcites →https://doi.org/10.1136/annrheumdis-2014-206034openalex-snapshot
Disease progression into adulthood and predictors of long-term active disease in juvenile idiopathic arthritis
inferredcites →https://doi.org/10.1136/ard-2022-223356openalex-snapshot
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
inferredcites →https://doi.org/10.1186/1471-2474-15-28openalex-snapshot
Measurement of stiffness in patients with rheumatoid arthritis in low disease activity or remission: a systematic review
inferredcites →https://doi.org/10.1186/s12969-019-0363-0openalex-snapshot
Enthesitis-related arthritis is the most common category of juvenile idiopathic arthritis in Taiwan and presents persistent active disease
inferredcites →https://doi.org/10.1186/s12969-019-0367-9openalex-snapshot
Complement lectin pathway protein levels reflect disease activity in juvenile idiopathic arthritis: a longitudinal study of the Nordic JIA cohort
inferredcites →https://doi.org/10.1186/s13075-018-1571-6openalex-snapshot
Predicting unfavorable long-term outcome in juvenile idiopathic arthritis: results from the Nordic cohort study
inferredcites →https://doi.org/10.1186/s13075-019-1994-8openalex-snapshot
Outcome in juvenile idiopathic arthritis: a population-based study from Sweden
inferredcites →https://doi.org/10.1186/s13075-020-02151-wopenalex-snapshot
A Canadian evaluation framework for quality improvement in childhood arthritis: key performance indicators of the process of care
inferredcites →https://doi.org/10.3109/03009742.2011.566433openalex-snapshot
Morning symptoms in rheumatoid arthritis: a defining characteristic and marker of active disease
inferredcites →https://doi.org/10.3109/03009749609104058openalex-snapshot
Clinical Assessment of the 1987 American College of Rheumatology Criteria for Rheumatoid Arthritis
inferredcites →https://doi.org/10.3899/jrheum.091474openalex-snapshot
Evaluation of 21-Numbered Circle and 10-Centimeter Horizontal Line Visual Analog Scales for Physician and Parent Subjective Ratings in Juvenile Idiopathic Arthritis
inferredcites →https://doi.org/10.3899/jrheum.120602openalex-snapshot
Disease Course, Outcome, and Predictors of Outcome in a Population-based Juvenile Chronic Arthritis Cohort Followed for 17 Years
inferredcites →https://doi.org/10.3899/jrheum.141172openalex-snapshot
More than Just Minutes of Stiffness in the Morning: Report from the OMERACT Rheumatoid Arthritis Flare Group Stiffness Breakout Sessions
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4048931openalex-extracted
Adalimumab Superior to Etanercept as First Line Biologic in ERA- a Drug Survival Single Centre Study Spanning 10 Years
inferred← citeshttps://doi.org/10.1002/acr.24735openalex-snapshot
“Every Little Furrow of Her Brow Makes Me Want To Stop”: An Interpretative Phenomenologic Analysis of Mothers' Experiences With Juvenile Idiopathic Arthritis Treatments
inferred← citeshttps://doi.org/10.1002/acr.24759openalex-snapshot
Musculoskeletal Ultrasound in Childhood Arthritis Limited Examination: A Comprehensive, Reliable, Time‐Efficient Assessment of Synovitis
inferred← citeshttps://doi.org/10.1002/acr.24853openalex-snapshot
2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis
inferred← citeshttps://doi.org/10.1002/acr.24857openalex-snapshot
Changing Patterns in Treatment, Remission Status, and Categories in a Long‐Term Nordic Cohort Study of Juvenile Idiopathic Arthritis
inferred← citeshttps://doi.org/10.1002/acr.24858openalex-snapshot
A Moving Target: Lessons From Long‐Term Studies in Juvenile Idiopathic Arthritis
inferred← citeshttps://doi.org/10.1002/acr.25465openalex-snapshot
Pharmacokinetics, Efficacy, and Safety of Upadacitinib in Pediatric Patients With Polyarticular‐Course Juvenile Idiopathic Arthritis: An Interim Analysis of an Open‐Label, Phase 1 Trial
inferred← citeshttps://doi.org/10.1002/acr2.11701openalex-snapshot
Predictors of Disease Activity in Patients With Juvenile Idiopathic Arthritis at 12 and 24 Months After Diagnosis
inferred← citeshttps://doi.org/10.1002/acr2.11758openalex-snapshot
Characteristics That Predict Psoriatic Arthritis by the Classification Criteria for Psoriatic Arthritis in Patients With Juvenile Idiopathic Arthritis 18 Years After Disease Onset
inferred← citeshttps://doi.org/10.1002/art.41888openalex-snapshot
Optimizing the Start Time of Biologics in Polyarticular Juvenile Idiopathic Arthritis: A Comparative Effectiveness Study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans
inferred← citeshttps://doi.org/10.1002/art.42037openalex-snapshot
2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis
inferred← citeshttps://doi.org/10.1002/art.42113openalex-snapshot
A Comparison of International League of Associations for Rheumatology and Pediatric Rheumatology International Trials Organization Classification Systems for Juvenile Idiopathic Arthritis Among Children in a Canadian Arthritis Cohort
inferred← citeshttps://doi.org/10.1002/art.42656openalex-snapshot
Recombinant Interleukin‐1 Receptor Antagonist Is an Effective First‐Line Treatment Strategy in New‐Onset Systemic Juvenile Idiopathic Arthritis, Irrespective of HLA‐DRB1 Background and IL1RN Variants
inferred← citeshttps://doi.org/10.1002/cpt.3441openalex-snapshot
Extrapolation of Upadacitinib Efficacy in Juvenile Idiopathic Arthritis Leveraging Pharmacokinetics, Exposure–Response Models, and Real‐World Patient Data
inferred← citeshttps://doi.org/10.1007/978-3-031-82102-8_7openalex-snapshot
Juvenile Idiopathic Arthritis in Adolescents and Young Adults
inferred← citeshttps://doi.org/10.1007/978-3-662-60410-6_26openalex-snapshot
Systemische Verlaufsform der juvenilen idiopathischen Arthritis (Morbus Still)
inferred← citeshttps://doi.org/10.1007/978-3-662-60410-6_27openalex-snapshot
Oligoartikuläre Verlaufsform der juvenilen idiopathischen Arthritis
inferred← citeshttps://doi.org/10.1007/978-3-662-60410-6_28openalex-snapshot
Polyartikuläre Verlaufsformen der juvenilen idiopathischen Arthritis
inferred← citeshttps://doi.org/10.1007/978-3-662-60410-6_30openalex-snapshot
Juvenile Psoriasisarthritis
inferred← citeshttps://doi.org/10.1007/978-3-662-60410-6_5openalex-snapshot
Genetik in der pädiatrischen Rheumatologie
inferred← citeshttps://doi.org/10.1007/978-3-662-60411-3_26-1openalex-snapshot
Systemische Verlaufsform der juvenilen idiopathischen Arthritis (Morbus Still)
inferred← citeshttps://doi.org/10.1007/978-3-662-60411-3_28-1openalex-snapshot
Polyartikuläre Verlaufsformen der juvenilen idiopathischen Arthritis
inferred← citeshttps://doi.org/10.1007/978-3-662-60411-3_5-1openalex-snapshot
Genetik in der pädiatrischen Rheumatologie
inferred← citeshttps://doi.org/10.1007/s00103-020-03173-0openalex-snapshot
Rheumatische Erkrankungen im Kindes- und Jugendalter: Wichtigkeit einer frühzeitigen multiprofessionellen Versorgung
inferred← citeshttps://doi.org/10.1007/s00296-020-04581-wopenalex-snapshot
Capturing the enthesitis related arthritis contemporary profile of Caucasian patients in the era of biologics
inferred← citeshttps://doi.org/10.1007/s00296-023-05274-wopenalex-snapshot
Recent updates in enthesitis-related arthritis
inferred← citeshttps://doi.org/10.1007/s00330-025-11891-9openalex-snapshot
ESR Essentials: juvenile idiopathic arthritis; what every radiologist needs to know—practice recommendations by the European Society of Paediatric Radiology
inferred← citeshttps://doi.org/10.1007/s00330-026-12627-zopenalex-snapshot
Reliability of CEUS and MRI for grading knee-joint inflammation in juvenile idiopathic arthritis
inferred← citeshttps://doi.org/10.1007/s00393-019-0648-1openalex-snapshot
Neue Therapiewege, bessere Outcomes?
inferred← citeshttps://doi.org/10.1007/s00431-025-06495-wopenalex-snapshot
Real-life data on treatment strategies for polyarticular juvenile idiopathic arthritis
inferred← citeshttps://doi.org/10.1007/s10067-025-07421-zopenalex-snapshot
One-year follow-up of a short specific carbohydrate diet intervention in children with juvenile idiopathic arthritis: A retrospectively controlled study with focus on medical burden
inferred← citeshttps://doi.org/10.1007/s10067-025-07444-6openalex-snapshot
Autoimmune/immune rheumatic diseases in family members of children with enthesitis related arthritis and other categories of juvenile idiopathic arthritis: a study from India
inferred← citeshttps://doi.org/10.1007/s11926-024-01145-wopenalex-snapshot
Paediatric Rheumatology Fails to Meet Current Benchmarks, a Call for Health Equity for Children Living with Juvenile Idiopathic Arthritis, Using Digital Health Technologies
inferred← citeshttps://doi.org/10.1007/s13312-025-00188-1openalex-snapshot
Impact of Biologic Therapy, School Success, Parent’s Education and Socioeconomic Status on Transition Readiness in Adolescents with Juvenile Idiopathic Arthritis and Their Parents
inferred← citeshttps://doi.org/10.1007/s40272-023-00618-2openalex-snapshot
Existing and Emerging Targeted Therapies in Juvenile Psoriatic Arthritis: Challenges and Unmet Needs
inferred← citeshttps://doi.org/10.1016/b978-0-443-11980-4.00011-8openalex-snapshot
Principles in the Management of Patients With Rheumatic Diseases
inferred← citeshttps://doi.org/10.1016/b978-0-443-23947-2.00006-0openalex-snapshot
Juvenile idiopathic arthritis
inferred← citeshttps://doi.org/10.1016/j.ard.2025.03.007openalex-snapshot
Identification and validation of interferon-driven gene signature as a predictor of response to methotrexate in juvenile idiopathic arthritis
inferred← citeshttps://doi.org/10.1016/j.autrev.2025.103805openalex-snapshot
Immunosenescence in autoimmune diseases
inferred← citeshttps://doi.org/10.1016/j.berh.2024.101984openalex-snapshot
A lifelong journey: Long-term perspectives on Juvenile Idiopathic Arthritis
inferred← citeshttps://doi.org/10.1016/j.berh.2026.102158openalex-snapshot
The young adult with Juvenile Idiopathic Arthritis (JIA): A clinical review of transition, complications, and psychosocial management
inferred← citeshttps://doi.org/10.1016/j.clim.2022.109170openalex-snapshot
Immunomodulation of neutrophils and platelets by TNF blockage in patients with juvenile idiopathic arthritis
inferred← citeshttps://doi.org/10.1016/j.jpeds.2023.113406openalex-snapshot
Inflammatory Biomarkers Can Differentiate Acute Lymphoblastic Leukemia with Arthropathy from Juvenile Idiopathic Arthritis Better Than Standard Blood Tests
inferred← citeshttps://doi.org/10.1016/j.neubiorev.2021.03.008openalex-snapshot
Left to themselves: Time to target chronic pain in childhood rare diseases
inferred← citeshttps://doi.org/10.1016/j.rdc.2021.06.003openalex-snapshot
Pathogenesis and Treatment of Refractory Disease Courses in Systemic Juvenile Idiopathic Arthritis
inferred← citeshttps://doi.org/10.1016/j.rdc.2021.07.009openalex-snapshot
Juvenile Idiopathic Arthritis Treatment Updates
inferred← citeshttps://doi.org/10.1016/j.reuma.2023.01.002openalex-snapshot
Artritis idiopática juvenil en el adulto joven. Metodología, objetivos y datos iniciales del registro JUVENSER
inferred← citeshttps://doi.org/10.1016/j.reuma.2025.501949openalex-snapshot
Real life treatment in juvenile idiopathic arthritis: Is remission long lasting?
inferred← citeshttps://doi.org/10.1016/j.reumae.2023.01.003openalex-snapshot
Juvenile idiopathic arthritis in the young adult. Methodology, objectives, and initial data from the JUVENSER registry
inferred← citeshttps://doi.org/10.1016/j.reumae.2025.501949openalex-snapshot
Real life treatment in juvenile idiopathic arthritis: Is remission long lasting?
inferred← citeshttps://doi.org/10.1016/j.semarthrit.2022.152038openalex-snapshot
Adalimumab or etanercept as first line biologic therapy in enthesitis related arthritis (ERA) - a drug-survival single centre study spanning 10 years
inferred← citeshttps://doi.org/10.1016/s2665-9913(24)00026-2openalex-snapshot
How can trial designs better serve the needs of children and young people with juvenile idiopathic arthritis?
inferred← citeshttps://doi.org/10.1017/jns.2024.92openalex-snapshot
Exploring nutritional risks of the specific carbohydrate diet: food and nutrient intake in children with juvenile idiopathic arthritis
inferred← citeshttps://doi.org/10.1038/s41572-021-00332-8openalex-snapshot
Juvenile idiopathic arthritis
inferred← citeshttps://doi.org/10.1055/a-2121-6546openalex-snapshot
Therapierefraktärer Verlauf einer extended-oligoartikulären juvenilen idiopathischen Arthritis
inferred← citeshttps://doi.org/10.1055/a-2733-9658openalex-snapshot
Rheuma bei Kindern und Jugendlichen – Teil 2
inferred← citeshttps://doi.org/10.1080/00365521.2022.2072691openalex-snapshot
Abdominal pain in Finnish young adults with juvenile idiopathic arthritis
inferred← citeshttps://doi.org/10.1080/03009742.2022.2040117openalex-snapshot
Transition to adult care in Finnish adolescents with juvenile idiopathic arthritis
inferred← citeshttps://doi.org/10.1080/07853890.2022.2095431openalex-snapshot
Refractory systemic onset juvenile idiopathic arthritis: current challenges and future perspectives
inferred← citeshttps://doi.org/10.1080/08998280.2025.2597640openalex-snapshot
Pregnancy outcomes in juvenile idiopathic arthritis: systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1093/mr/roae016openalex-snapshot
Evaluation of medication withdrawal in patients with non-systemic juvenile idiopathic arthritis in Japan using a web-based survey
inferred← citeshttps://doi.org/10.1093/mr/roae036openalex-snapshot
Predictors of disease course in systemic juvenile idiopathic arthritis
inferred← citeshttps://doi.org/10.1093/mr/roag075openalex-snapshot
Clinical characteristics of enthesitis-related arthritis and outcomes of treatment with salazosulfapyridine
inferred← citeshttps://doi.org/10.1093/rap/rkad062openalex-snapshot
A population-based study of caesarean section in women with juvenile idiopathic arthritis
inferred← citeshttps://doi.org/10.1093/rap/rkz031openalex-snapshot
Short-term outcome of surgical arthrodiastasis of the ankle with Ilizarov frame in a cohort of children and young people with juvenile idiopathic arthritis
inferred← citeshttps://doi.org/10.1093/rheumatology/keab150openalex-snapshot
Patients with psychiatric diagnoses have lower quality of life than other patients with juvenile rheumatic disease: a prospective study
inferred← citeshttps://doi.org/10.1093/rheumatology/keab673openalex-snapshot
Interfering with interferons: targeting the JAK-STAT pathway in complications of systemic juvenile idiopathic arthritis (SJIA)
inferred← citeshttps://doi.org/10.1093/rheumatology/keac312openalex-snapshot
Is time a healer? How quality of life changes over time reported by parents of children and young people with juvenile idiopathic arthritis
inferred← citeshttps://doi.org/10.1093/rheumatology/keac335openalex-snapshot
Trajectories of disease activity in patients with JIA in the Childhood Arthritis and Rheumatology Research Alliance Registry
inferred← citeshttps://doi.org/10.1093/rheumatology/keac440openalex-snapshot
JAK inhibitors in difficult-to-treat adult-onset Still’s disease and systemic-onset juvenile idiopathic arthritis
inferred← citeshttps://doi.org/10.1093/rheumatology/kead032openalex-snapshot
Predictors of long-term functional outcomes of juvenile idiopathic arthritis–enthesitis-related arthritis: a single centre experience
inferred← citeshttps://doi.org/10.1093/rheumatology/kead370openalex-snapshot
The impact of psoriasis on wellbeing and clinical outcomes in juvenile psoriatic arthritis
inferred← citeshttps://doi.org/10.1093/rheumatology/keae039openalex-snapshot
Detection of inflammation by whole-body MRI in young people with juvenile idiopathic arthritis
inferred← citeshttps://doi.org/10.1093/rheumatology/keag272openalex-snapshot
Risk-updating nomogram for refractory systemic JIA in children: multicentre development and external validation
inferred← citeshttps://doi.org/10.1093/rheumatology/keag507openalex-snapshot
Comorbidity and mortality in adults with juvenile idiopathic arthritis: a nationwide Norwegian register-based matched cohort study
inferred← citeshttps://doi.org/10.1097/rhu.0000000000002032openalex-snapshot
Can Whole-Body Magnetic Resonance Imaging Predict Relapse in Juvenile Idiopathic Arthritis? A Longitudinal Pilot Study
inferred← citeshttps://doi.org/10.1097/rhu.0000000000002055openalex-snapshot
Transition From Pediatric to Adult Rheumatology Care
inferred← citeshttps://doi.org/10.1111/1756-185x.14277openalex-snapshot
Transition readiness assessment in adolescents and young adults with rheumatic diseases: The Singapore experience
inferred← citeshttps://doi.org/10.1111/1756-185x.15189openalex-snapshot
Three‐ and five‐year outcomes of an inception cohort of Australian children with juvenile idiopathic arthritis
inferred← citeshttps://doi.org/10.1111/1756-185x.70176openalex-snapshot
Clinical Features and Risk Factors for Early Bone Destruction in Enthesitis‐Related Arthritis: A Cohort Study
inferred← citeshttps://doi.org/10.1136/archdischild-2021-322114openalex-snapshot
M-ficolin: a valuable biomarker to identify leukaemia from juvenile idiopathic arthritis
inferred← citeshttps://doi.org/10.1136/ard-2022-222553openalex-snapshot
Towards molecular-pathology informed clinical trials in childhood arthritis to achieve precision medicine in juvenile idiopathic arthritis
inferred← citeshttps://doi.org/10.1136/rmdopen-2021-001766openalex-snapshot
Health-related quality of life and disability in adults with juvenile idiopathic arthritis: comparison with adult-onset rheumatic diseases
inferred← citeshttps://doi.org/10.1136/rmdopen-2022-002901openalex-snapshot
Children with extended oligoarticular and polyarticular juvenile idiopathic arthritis have alterations in B and T follicular cell subsets in peripheral blood and a cytokine profile sustaining B cell activation
inferred← citeshttps://doi.org/10.1136/rmdopen-2023-003759openalex-snapshot
Disease activity trajectories from childhood to adulthood in the population-based Nordic juvenile idiopathic arthritis cohort
inferred← citeshttps://doi.org/10.1136/rmdopen-2024-004317openalex-snapshot
Inflammatory biomarkers predicting long-term remission and active disease in juvenile idiopathic arthritis: a population-based study of the Nordic JIA cohort
inferred← citeshttps://doi.org/10.1136/rmdopen-2024-005369openalex-snapshot
Age at diagnosis as a prognostic factor in selected categories of juvenile idiopathic arthritis
inferred← citeshttps://doi.org/10.1177/09733698241256530openalex-snapshot
Systemic Juvenile Idiopathic Arthritis: The Challenges and Opportunities
inferred← citeshttps://doi.org/10.1186/s12887-023-04181-0openalex-snapshot
An explorative study on proteomic analyses related to inflammation and pain in children with juvenile idiopathic arthritis
inferred← citeshttps://doi.org/10.1186/s12891-022-06028-8openalex-snapshot
Enthesitis-related arthritis: the clinical characteristics and factors related to MRI remission of sacroiliitis
inferred← citeshttps://doi.org/10.1186/s12891-024-08051-3openalex-snapshot
Factors associated with sarcopenia among young adults with juvenile idiopathic arthritis: a cross-sectional study
inferred← citeshttps://doi.org/10.1186/s12969-019-0341-6openalex-snapshot
Participation in school and physical education in juvenile idiopathic arthritis in a Nordic long-term cohort study
inferred← citeshttps://doi.org/10.1186/s12969-019-0363-0openalex-snapshot
Enthesitis-related arthritis is the most common category of juvenile idiopathic arthritis in Taiwan and presents persistent active disease
inferred← citeshttps://doi.org/10.1186/s12969-019-0367-9openalex-snapshot
Complement lectin pathway protein levels reflect disease activity in juvenile idiopathic arthritis: a longitudinal study of the Nordic JIA cohort
inferred← citeshttps://doi.org/10.1186/s12969-021-00499-0openalex-snapshot
Fatigue in young adults with juvenile idiopathic arthritis 18 years after disease onset: data from the prospective Nordic JIA cohort
inferred← citeshttps://doi.org/10.1186/s12969-021-00577-3openalex-snapshot
A pilot study of possible anti-inflammatory effects of the specific carbohydrate diet in children with juvenile idiopathic arthritis
inferred← citeshttps://doi.org/10.1186/s12969-021-00602-5openalex-snapshot
Assessment of transition readiness in adolescents in Thailand with rheumatic diseases: a cross-sectional study
inferred← citeshttps://doi.org/10.1186/s12969-021-00613-2openalex-snapshot
Frequency of juvenile idiopathic arthritis and associated uveitis in pediatric rheumatology clinics in Turkey: A retrospective study, JUPITER
inferred← citeshttps://doi.org/10.1186/s12969-022-00682-xopenalex-snapshot
Real-world data reveals the complexity of disease modifying anti-rheumatic drug treatment patterns in juvenile idiopathic arthritis: an observational study
inferred← citeshttps://doi.org/10.1186/s12969-022-00742-2openalex-snapshot
Transitioning patients with juvenile idiopathic arthritis to adult care: the Nordic experience
inferred← citeshttps://doi.org/10.1186/s12969-022-00748-wopenalex-snapshot
Economic evaluation of infliximab, synthetic triple therapy and methotrexate in the treatment of newly diagnosed juvenile idiopathic arthritis
inferred← citeshttps://doi.org/10.1186/s12969-022-00765-9openalex-snapshot
The risk of depression and anxiety is not increased in individuals with juvenile idiopathic arthritis – results from the south-Swedish juvenile idiopathic arthritis cohort
inferred← citeshttps://doi.org/10.1186/s12969-023-00792-0openalex-snapshot
Axial involvement in enthesitis-related arthritis: results from a single-center cohort
inferred← citeshttps://doi.org/10.1186/s12969-023-00796-wopenalex-snapshot
Subtype frequency, demographic features, treatment and outcome of Juvenile Arthritis in one Centre in Abu Dhabi in the United Arab Emirates
inferred← citeshttps://doi.org/10.1186/s12969-023-00810-1openalex-snapshot
The effect of TNF treatment uptake on incident hospital admission in Western Australia
inferred← citeshttps://doi.org/10.1186/s12969-023-00811-0openalex-snapshot
Adherence, helpfulness and barriers to treatment in juvenile idiopathic arthritis – data from a German Inception cohort
inferred← citeshttps://doi.org/10.1186/s12969-023-00865-0openalex-snapshot
The 4th NextGen therapies for SJIA and MAS: part 2 phenotypes of refractory SJIA and the landscape for clinical trials in refractory SJIA
inferred← citeshttps://doi.org/10.1186/s12969-023-00878-9openalex-snapshot
Disease characteristics of HLA-B27 positive and negative finnish patients with juvenile idiopathic arthritis - results of the 18-year cohort follow-up study
inferred← citeshttps://doi.org/10.1186/s12969-023-00897-6openalex-snapshot
Biologic switching patterns among children with non-systemic juvenile idiopathic arthritis
inferred← citeshttps://doi.org/10.1186/s12969-023-00914-8openalex-snapshot
A qualitative evaluation of the specific carbohydrate diet for juvenile idiopathic arthritis based on children’s and parents’ experiences
inferred← citeshttps://doi.org/10.1186/s12969-023-00931-7openalex-snapshot
Body mass index is associated with health-related quality of life and disease characteristics in young adults with juvenile idiopathic arthritis
inferred← citeshttps://doi.org/10.1186/s12969-023-00938-0openalex-snapshot
Transition readiness among finnish adolescents with juvenile idiopathic arthritis
inferred← citeshttps://doi.org/10.1186/s12969-024-00972-6openalex-snapshot
Serum and salivary inflammatory biomarkers in juvenile idiopathic arthritis—an explorative cross-sectional study
inferred← citeshttps://doi.org/10.1186/s12969-024-01030-xopenalex-snapshot
Screening for comorbid autoimmune disease should be considered in children with ANA positive juvenile idiopathic arthritis – results from the south-Swedish juvenile idiopathic arthritis cohort
inferred← citeshttps://doi.org/10.1186/s12969-024-01034-7openalex-snapshot
The patient’s voice: a cross-sectional study of physical health and disability in juvenile idiopathic arthritis
inferred← citeshttps://doi.org/10.1186/s12969-025-01065-8openalex-snapshot
Epidemiology and comorbidity of juvenile idiopathic arthritis in Poland– a nationwide study
inferred← citeshttps://doi.org/10.1186/s12969-025-01070-xopenalex-snapshot
What have we learned from long-term studies in juvenile idiopathic arthritis? – Prediction, classification, transition.
inferred← citeshttps://doi.org/10.1186/s12969-025-01075-6openalex-snapshot
Clinical remission rate and drug withdrawal status in articular juvenile idiopathic arthritis
inferred← citeshttps://doi.org/10.1186/s12969-025-01171-7openalex-snapshot
Predictors of relapse after withdrawing biotherapies in children with inactive juvenile idiopathic arthritis: a retrospective cohort study of the JIR cohort
inferred← citeshttps://doi.org/10.1186/s13075-019-1994-8openalex-snapshot
Outcome in juvenile idiopathic arthritis: a population-based study from Sweden
inferred← citeshttps://doi.org/10.1186/s13075-020-02151-wopenalex-snapshot
A Canadian evaluation framework for quality improvement in childhood arthritis: key performance indicators of the process of care
inferred← citeshttps://doi.org/10.1186/s13075-020-02345-2openalex-snapshot
Pain sensitivity in young adults with juvenile idiopathic arthritis: a quantitative sensory testing study
inferred← citeshttps://doi.org/10.1186/s13075-021-02483-1openalex-snapshot
Synovial fluid neutrophils in oligoarticular juvenile idiopathic arthritis have an altered phenotype and impaired effector functions
inferred← citeshttps://doi.org/10.1186/s13075-023-03166-9openalex-snapshot
Influence of the timing of biological treatment initiation on Juvenile Idiopathic Arthritis long-term outcomes
inferred← citeshttps://doi.org/10.1186/s13075-025-03717-2openalex-snapshot
Novel insights into the biology of childhood arthritis- lessons learned from the synovium
inferred← citeshttps://doi.org/10.1186/s40348-023-00168-0openalex-snapshot
A novel serum calprotectin (MRP8/14) particle-enhanced immuno-turbidimetric assay (sCAL turbo) helps to differentiate systemic juvenile idiopathic arthritis from other diseases in routine clinical laboratory settings
inferred← citeshttps://doi.org/10.1186/s41927-025-00492-0openalex-snapshot
Involving young people in research investigating comorbidity associated with childhood-onset rheumatic disease: perspectives of a series of focus groups
inferred← citeshttps://doi.org/10.1186/s42358-024-00378-8openalex-snapshot
Presentation of enthesitis-related arthritis and juvenile-onset spondyloarthritis: a cross-sectional study in a pediatric and adult clinic
inferred← citeshttps://doi.org/10.12703/r/10-23openalex-snapshot
Recent progress in the treatment of non-systemic juvenile idiopathic arthritis
inferred← citeshttps://doi.org/10.18663/tjcl.1912780openalex-snapshot
Evaluation of clinical and radiological findings in children with juvenile idiopathic arthritis
inferred← citeshttps://doi.org/10.21203/rs.2.22438/v1openalex-snapshot
Anti-inflammatory effect of the specific carbohydrate diet in children with juvenile idiopathic arthritis
inferred← citeshttps://doi.org/10.21203/rs.2.22438/v2openalex-snapshot
Anti-inflammatory effect of the specific carbohydrate diet in children with juvenile idiopathic arthritis
inferred← citeshttps://doi.org/10.21203/rs.3.rs-10701264/v1openalex-snapshot
Juvenile-onset spondyloarthritis: 17-year outcomes and comparison with late adult-onset disease. Results from the REGISPON-3 cohort
inferred← citeshttps://doi.org/10.21203/rs.3.rs-1151778/v1openalex-snapshot
Increasing Incidence of Juvenile Idiopathic Arthritis: A Trend Over 31 Years in Southern Sweden
inferred← citeshttps://doi.org/10.21203/rs.3.rs-150762/v1openalex-snapshot
A Pilot Study of Possible Anti-Inflammatory Effects of The Specific Carbohydrate Diet in Children with Juvenile Idiopathic Arthritis
inferred← citeshttps://doi.org/10.21203/rs.3.rs-1847261/v1openalex-snapshot
Proteomic analyses related to inflammation and pain in children with juvenile idiopathic arthritis
inferred← citeshttps://doi.org/10.21203/rs.3.rs-2725312/v1openalex-snapshot
Effect of Ixekizumab on Enthesitis-related arthritis non-responsive to anti-TNF treatment, a case report
inferred← citeshttps://doi.org/10.21203/rs.3.rs-285837/v1openalex-snapshot
Assessment of Transition Readiness in Adolescents with Rheumatic Diseases: A Cross-Sectional Study
inferred← citeshttps://doi.org/10.21203/rs.3.rs-3272472/v1openalex-snapshot
A novel serum calprotectin (MRP8/14) particle enhanced immuno-turbidimetric assay (sCAL turbo) helps to differentiate systemic juvenile idiopathic arthritis from other diseases in routine clinical laboratory settings
inferred← citeshttps://doi.org/10.21755/mto.2024.067.0001.005openalex-snapshot
Successful treatment of a challenging periprosthetic femoral fracture on a premenopausal patient with a long history of immunosuppression
inferred← citeshttps://doi.org/10.22141/pjs.13.2.2023.372openalex-snapshot
Handgrip strength, physical activity, and body composition in young adults with juvenile idiopathic arthritis
inferred← citeshttps://doi.org/10.3389/fimmu.2023.1229520openalex-snapshot
Expanded population of low-density neutrophils in juvenile idiopathic arthritis
inferred← citeshttps://doi.org/10.3389/flupu.2024.1375857openalex-snapshot
Preterm birth, preeclampsia, gestational hypertension and offspring birth weight in women with active juvenile idiopathic arthritis and healthy controls
inferred← citeshttps://doi.org/10.3389/fmed.2022.971121openalex-snapshot
Increased histone citrullination in juvenile idiopathic arthritis
inferred← citeshttps://doi.org/10.3389/fped.2025.1535223openalex-snapshot
Disease activity and treatment in patients with juvenile idiopathic arthritis before transfer to adult care: the first survey in China
inferred← citeshttps://doi.org/10.3389/fphar.2020.635823openalex-snapshot
Biomarkers of Response to Biologic Therapy in Juvenile Idiopathic Arthritis
inferred← citeshttps://doi.org/10.3389/fpubh.2025.1531764openalex-snapshot
Development of a machine learning-based predictive nomogram for screening children with juvenile idiopathic arthritis: a pseudo-longitudinal study of 223,195 children in the United States
inferred← citeshttps://doi.org/10.3390/biomedicines10030723openalex-snapshot
Production and Secretion of Gelsolin by Both Human Macrophage- and Fibroblast-like Synoviocytes and GSN Modulation in the Synovial Fluid of Patients with Various Forms of Arthritis
inferred← citeshttps://doi.org/10.3390/children10101647openalex-snapshot
Advances in the Diagnosis and Treatment of Enthesitis-Related Arthritis
inferred← citeshttps://doi.org/10.3390/children11070881openalex-snapshot
The TRUST Study—TRansition US Together: Evaluating the Impact of a Parent- and Adolescent-Centered Transition Toolkit on Transition Readiness in Patients with Juvenile Idiopathic Arthritis and Childhood-Onset Systemic Lupus Erythematosus
inferred← citeshttps://doi.org/10.3390/children13080995openalex-snapshot
Comorbidities in Juvenile-Onset Rheumatic Diseases: A Systematic Review and Meta-Analysis
inferred← citeshttps://doi.org/10.3390/diagnostics16203305openalex-snapshot
Positivity Rates and Serum Levels of Antibodies Against Histone H3 Lysine 9 and Its Lactylated Form in Rheumatoid Arthritis and Its Mimics
inferred← citeshttps://doi.org/10.3390/healthcare12030392openalex-snapshot
Using Digital Health Technologies to Monitor Pain, Medication Adherence and Physical Activity in Young People with Juvenile Idiopathic Arthritis: A Feasibility Study
inferred← citeshttps://doi.org/10.3390/ijms26031189openalex-snapshot
Early Anti-Drug Antibodies Predict Adalimumab Response in Juvenile Idiopathic Arthritis
inferred← citeshttps://doi.org/10.3390/life14060712openalex-snapshot
Treatment Patterns in Polyarticular Juvenile Idiopathic Arthritis: A Retrospective Observational Health Claims Data Study
inferred← citeshttps://doi.org/10.3390/pathophysiology28030021openalex-snapshot
A Proteinase 3 Contribution to Juvenile Idiopathic Arthritis-Associated Cartilage Damage
inferred← citeshttps://doi.org/10.3390/rheumato6020009openalex-snapshot
Treat-to-Target Strategies and Early Biologic Initiation in Polyarticular Juvenile Idiopathic Arthritis: Translating Evidence into Clinical Practice
inferred← citeshttps://doi.org/10.3899/jrheum.2023-0783openalex-snapshot
Clinical Characteristics of Adolescents With Juvenile Idiopathic Arthritis Transitioning to Adult Rheumatology Care in Canada: Results From the CAPRI Registry
inferred← citeshttps://doi.org/10.3899/jrheum.2025-0313openalex-snapshot
Evaluation of Health Disparities in Outcomes of Patients With Juvenile Idiopathic Arthritis
inferred← citeshttps://doi.org/10.3899/jrheum.2025-0384openalex-snapshot
Health-Related Quality of Life in Disease-Modifying Antirheumatic Drug–Treated Adults With Juvenile Idiopathic Arthritis Compared to Rheumatoid Arthritis and the General Population
inferred← citeshttps://doi.org/10.3899/jrheum.211245openalex-snapshot
Personally Generated Quality of Life Outcomes in Adults With Juvenile Idiopathic Arthritis
inferred← citeshttps://doi.org/10.3899/jrheum.220514openalex-snapshot
Patient-Reported Outcomes Among Transition-Age Young Adults With Juvenile Idiopathic Arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry
inferred← citeshttps://doi.org/10.3899/jrheum.220645openalex-snapshot
Treatment Response to Tumor Necrosis Factor Inhibitors and Methotrexate Monotherapy in Adults With Juvenile Idiopathic Arthritis: Data From NOR-DMARD
inferred← citeshttps://doi.org/10.4236/ojped.2020.104078openalex-snapshot
Current Review of Systemic Juvenile Idiopathic Arthritis: What Do Paediatricians Need to Know?
inferred← citeshttps://doi.org/10.46497/archrheumatol.2022.9219openalex-snapshot
Transition readiness in adolescents with juvenile idiopathic arthritis and their parents: Our single-center experience
inferred← citeshttps://doi.org/10.5435/jaaos-d-24-01320openalex-snapshot
Management of the Upper Extremity in Juvenile Idiopathic Arthritis
inferred← citeshttps://doi.org/10.55563/clinexprheumatol/nzsv4gopenalex-snapshot
Consumer perspective on healthcare services for juvenile idiopathic arthritis: results of a multicentre JIA inception cohort study
inferred← citeshttps://doi.org/10.5582/irdr.2025.01035openalex-snapshot
Literature analysis and implication of biologic therapy for children with non-systemic juvenile idiopathic arthritis in real-world settings
inferred← citeshttps://doi.org/10.6084/m9.figshare.13199061openalex-snapshot
Additional file 1 of Pain sensitivity in young adults with juvenile idiopathic arthritis: a quantitative sensory testing study
inferred← citeshttps://doi.org/10.6084/m9.figshare.13199064openalex-snapshot
Additional file 2 of Pain sensitivity in young adults with juvenile idiopathic arthritis: a quantitative sensory testing study
inferred← citeshttps://doi.org/10.6084/m9.figshare.13199067openalex-snapshot
Additional file 3 of Pain sensitivity in young adults with juvenile idiopathic arthritis: a quantitative sensory testing study
inferred← citeshttps://doi.org/10.6084/m9.figshare.13199070openalex-snapshot
Additional file 4 of Pain sensitivity in young adults with juvenile idiopathic arthritis: a quantitative sensory testing study
inferred← citeshttps://doi.org/10.6084/m9.figshare.14396841openalex-snapshot
Additional file 1 of Synovial fluid neutrophils in oligoarticular juvenile idiopathic arthritis have an altered phenotype and impaired effector functions
inferred← citeshttps://doi.org/10.6084/m9.figshare.14396844openalex-snapshot
Additional file 2 of Synovial fluid neutrophils in oligoarticular juvenile idiopathic arthritis have an altered phenotype and impaired effector functions
inferred← citeshttps://doi.org/10.6084/m9.figshare.19582372openalex-snapshot
Additional file 1 of Real-world data reveals the complexity of disease modifying anti-rheumatic drug treatment patterns in juvenile idiopathic arthritis: an observational study
inferred← citeshttps://doi.org/10.6084/m9.figshare.23691168openalex-snapshot
Additional file 1 of An explorative study on proteomic analyses related to inflammation and pain in children with juvenile idiopathic arthritis
inferred← citeshttps://doi.org/10.6084/m9.figshare.23691171openalex-snapshot
Additional file 2 of An explorative study on proteomic analyses related to inflammation and pain in children with juvenile idiopathic arthritis
inferred← citeshttps://doi.org/10.6084/m9.figshare.23691174openalex-snapshot
Additional file 3 of An explorative study on proteomic analyses related to inflammation and pain in children with juvenile idiopathic arthritis
inferred← citeshttps://doi.org/10.6084/m9.figshare.23691177openalex-snapshot
Additional file 4 of An explorative study on proteomic analyses related to inflammation and pain in children with juvenile idiopathic arthritis
inferred← citeshttps://doi.org/10.6084/m9.figshare.23691180openalex-snapshot
Additional file 5 of An explorative study on proteomic analyses related to inflammation and pain in children with juvenile idiopathic arthritis
inferred← citeshttps://doi.org/10.6084/m9.figshare.23691183openalex-snapshot
Additional file 6 of An explorative study on proteomic analyses related to inflammation and pain in children with juvenile idiopathic arthritis
inferred← citeshttps://doi.org/10.6084/m9.figshare.23691186openalex-snapshot
Additional file 7 of An explorative study on proteomic analyses related to inflammation and pain in children with juvenile idiopathic arthritis
inferred← citeshttps://doi.org/10.6084/m9.figshare.24406631openalex-snapshot
Additional file 1 of A qualitative evaluation of the specific carbohydrate diet for juvenile idiopathic arthritis based on children’s and parents’ experiences
inferred← citeshttps://doi.org/10.6084/m9.figshare.24406934openalex-snapshot
Additional file 2 of A qualitative evaluation of the specific carbohydrate diet for juvenile idiopathic arthritis based on children’s and parents’ experiences
inferred← citeshttps://doi.org/10.6084/m9.figshare.24439315openalex-snapshot
Additional file 1 of A novel serum calprotectin (MRP8/14) particle-enhanced immuno-turbidimetric assay (sCAL turbo) helps to differentiate systemic juvenile idiopathic arthritis from other diseases in routine clinical laboratory settings
inferred← citeshttps://doi.org/10.6084/m9.figshare.24439460openalex-snapshot
Additional file 2 of A novel serum calprotectin (MRP8/14) particle-enhanced immuno-turbidimetric assay (sCAL turbo) helps to differentiate systemic juvenile idiopathic arthritis from other diseases in routine clinical laboratory settings
inferred← citeshttps://doi.org/10.6084/m9.figshare.25376129openalex-snapshot
Additional file 1 of Serum and salivary inflammatory biomarkers in juvenile idiopathic arthritis—an explorative cross-sectional study
inferred← citeshttps://doi.org/10.6084/m9.figshare.25376165openalex-snapshot
Additional file 2 of Serum and salivary inflammatory biomarkers in juvenile idiopathic arthritis—an explorative cross-sectional study
inferred← citeshttps://doi.org/10.6084/m9.figshare.26578196openalex-snapshot
Additional file 1 of The effect of TNF treatment uptake on incident hospital admission in Western Australia
inferred← citeshttps://doi.org/10.6084/m9.figshare.26581739openalex-snapshot
Additional file 1 of Adherence, helpfulness and barriers to treatment in juvenile idiopathic arthritis – data from a German Inception cohort
inferred← citeshttps://doi.org/10.6084/m9.figshare.26691244openalex-snapshot
Additional file 3 of Serum and salivary inflammatory biomarkers in juvenile idiopathic arthritis—an explorative cross-sectional study
inferred← citeshttps://doi.org/10.6084/m9.figshare.26691247openalex-snapshot
Additional file 4 of Serum and salivary inflammatory biomarkers in juvenile idiopathic arthritis—an explorative cross-sectional study
inferred← citeshttps://doi.org/10.61409/v09240622openalex-snapshot
The role of Janus kinase inhibitors in the treatment of juvenile idiopathic arthritis
inferred← citeshttps://doi.org/10.7759/cureus.84770openalex-snapshot
Tofacitinib in the Treatment of Refractory Adult-Onset Still’s Disease Co-diagnosed With Celiac Disease: A Case Report
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.